Despite the limited number of patients, our results align with a pivotal German study, which reported that 77% of Ph+ ALL cases expressed the p190 transcript, 20% the p210 transcript, and 3% co-expressed both [6]. This evidence concerns the gene EVPL and acute lymphoblastic leukemia.